filmov
tv
Sydney Addiction Seminars: Medicinal cannabis in 2021 – When, Why and How?
Показать описание
This seminar series is kindly sponsored by Indivior.
Australia’s medicinal cannabis industry has rapidly expanded in the last few years, with now dozens of listed manufacturers and suppliers, clinics and dispensing services, advocacy and information services, and often with links between them. The task of obtaining necessary authorities (Therapeutic Goods Administration (TGA), state health departments and the Office of Drug Control) has been made easier by the TGA providing a one-stop application portal and by clinics of various kinds that facilitate the application process that typically also prescribe the medication.
For what conditions should cannabinoid products be prescribed? Are they effective and safe? How, in what formulations and by whom should they be prescribed? Do certain medical professionals, like general practitioners or nurse practitioners, have a place in this or is it best left to those with a special interest or expertise? How does this relate to the alcohol and other drugs (AOD) field at this time?
This seminar will include presentations and discussions from Dr Mark Hardy and Prof Nick Lintzeris, with the session chaired by Prof Paul Haber.
Connect with us:
Australia’s medicinal cannabis industry has rapidly expanded in the last few years, with now dozens of listed manufacturers and suppliers, clinics and dispensing services, advocacy and information services, and often with links between them. The task of obtaining necessary authorities (Therapeutic Goods Administration (TGA), state health departments and the Office of Drug Control) has been made easier by the TGA providing a one-stop application portal and by clinics of various kinds that facilitate the application process that typically also prescribe the medication.
For what conditions should cannabinoid products be prescribed? Are they effective and safe? How, in what formulations and by whom should they be prescribed? Do certain medical professionals, like general practitioners or nurse practitioners, have a place in this or is it best left to those with a special interest or expertise? How does this relate to the alcohol and other drugs (AOD) field at this time?
This seminar will include presentations and discussions from Dr Mark Hardy and Prof Nick Lintzeris, with the session chaired by Prof Paul Haber.
Connect with us:
1:35:41
0:14:49
1:28:25
1:58:18
1:35:47
1:49:32
1:29:07
1:48:52
0:37:51
0:01:52
0:08:17
0:00:18
0:23:42
0:01:00
0:56:38
0:40:48
0:27:57
0:00:28
0:46:45
1:09:56
0:50:06
1:00:22
1:04:31
0:55:36